These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
731 related articles for article (PubMed ID: 17183323)
1. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Ridgway J; Zhang G; Wu Y; Stawicki S; Liang WC; Chanthery Y; Kowalski J; Watts RJ; Callahan C; Kasman I; Singh M; Chien M; Tan C; Hongo JA; de Sauvage F; Plowman G; Yan M Nature; 2006 Dec; 444(7122):1083-7. PubMed ID: 17183323 [TBL] [Abstract][Full Text] [Related]
2. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Noguera-Troise I; Daly C; Papadopoulos NJ; Coetzee S; Boland P; Gale NW; Lin HC; Yancopoulos GD; Thurston G Nature; 2006 Dec; 444(7122):1032-7. PubMed ID: 17183313 [TBL] [Abstract][Full Text] [Related]
3. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Hellström M; Phng LK; Hofmann JJ; Wallgard E; Coultas L; Lindblom P; Alva J; Nilsson AK; Karlsson L; Gaiano N; Yoon K; Rossant J; Iruela-Arispe ML; Kalén M; Gerhardt H; Betsholtz C Nature; 2007 Feb; 445(7129):776-80. PubMed ID: 17259973 [TBL] [Abstract][Full Text] [Related]
4. [Influence of Delta-like ligand 4/Notch signal transduction pathway upon the biological behavior of human umbilical vein endothelial cells]. Chen L; Lü W; Wei B; Wang N; Li T Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(44):3106-10. PubMed ID: 20193271 [TBL] [Abstract][Full Text] [Related]
5. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Lobov IB; Renard RA; Papadopoulos N; Gale NW; Thurston G; Yancopoulos GD; Wiegand SJ Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3219-24. PubMed ID: 17296940 [TBL] [Abstract][Full Text] [Related]
6. New pathways and mechanisms regulating and responding to Delta-like ligand 4-Notch signalling in tumour angiogenesis. Oon CE; Harris AL Biochem Soc Trans; 2011 Dec; 39(6):1612-8. PubMed ID: 22103496 [TBL] [Abstract][Full Text] [Related]
7. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo. Li JL; Sainson RC; Shi W; Leek R; Harrington LS; Preusser M; Biswas S; Turley H; Heikamp E; Hainfellner JA; Harris AL Cancer Res; 2007 Dec; 67(23):11244-53. PubMed ID: 18056450 [TBL] [Abstract][Full Text] [Related]
8. The role of the vascular endothelial growth factor-Delta-like 4 ligand/Notch4-ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions. Hainaud P; Contrerès JO; Villemain A; Liu LX; Plouët J; Tobelem G; Dupuy E Cancer Res; 2006 Sep; 66(17):8501-10. PubMed ID: 16951162 [TBL] [Abstract][Full Text] [Related]
9. Delta-like 4/Notch signaling and its therapeutic implications. Yan M; Plowman GD Clin Cancer Res; 2007 Dec; 13(24):7243-6. PubMed ID: 18094402 [TBL] [Abstract][Full Text] [Related]
10. Anti-Dll4 therapy: can we block tumour growth by increasing angiogenesis? Sainson RC; Harris AL Trends Mol Med; 2007 Sep; 13(9):389-95. PubMed ID: 17822956 [TBL] [Abstract][Full Text] [Related]
11. Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate. Diez H; Fischer A; Winkler A; Hu CJ; Hatzopoulos AK; Breier G; Gessler M Exp Cell Res; 2007 Jan; 313(1):1-9. PubMed ID: 17045587 [TBL] [Abstract][Full Text] [Related]
12. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Patel NS; Li JL; Generali D; Poulsom R; Cranston DW; Harris AL Cancer Res; 2005 Oct; 65(19):8690-7. PubMed ID: 16204037 [TBL] [Abstract][Full Text] [Related]
13. VEGFRs and Notch: a dynamic collaboration in vascular patterning. Jakobsson L; Bentley K; Gerhardt H Biochem Soc Trans; 2009 Dec; 37(Pt 6):1233-6. PubMed ID: 19909253 [TBL] [Abstract][Full Text] [Related]
15. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells. Harrington LS; Sainson RC; Williams CK; Taylor JM; Shi W; Li JL; Harris AL Microvasc Res; 2008 Mar; 75(2):144-54. PubMed ID: 17692341 [TBL] [Abstract][Full Text] [Related]
16. Regulation of angiogenesis by homotypic and heterotypic notch signalling in endothelial cells and pericytes: from basic research to potential therapies. Sainson RC; Harris AL Angiogenesis; 2008; 11(1):41-51. PubMed ID: 18256896 [TBL] [Abstract][Full Text] [Related]
17. Modulation of VEGF signalling output by the Notch pathway. Siekmann AF; Covassin L; Lawson ND Bioessays; 2008 Apr; 30(4):303-13. PubMed ID: 18348190 [TBL] [Abstract][Full Text] [Related]
18. DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo. Li JL; Sainson RC; Oon CE; Turley H; Leek R; Sheldon H; Bridges E; Shi W; Snell C; Bowden ET; Wu H; Chowdhury PS; Russell AJ; Montgomery CP; Poulsom R; Harris AL Cancer Res; 2011 Sep; 71(18):6073-83. PubMed ID: 21803743 [TBL] [Abstract][Full Text] [Related]
19. Regulatory T cells negatively regulate neovasculature of airway remodeling via DLL4-Notch signaling. Huang MT; Dai YS; Chou YB; Juan YH; Wang CC; Chiang BL J Immunol; 2009 Oct; 183(7):4745-54. PubMed ID: 19752226 [TBL] [Abstract][Full Text] [Related]
20. Synaptojanin-2 binding protein stabilizes the Notch ligands DLL1 and DLL4 and inhibits sprouting angiogenesis. Adam MG; Berger C; Feldner A; Yang WJ; Wüstehube-Lausch J; Herberich SE; Pinder M; Gesierich S; Hammes HP; Augustin HG; Fischer A Circ Res; 2013 Nov; 113(11):1206-18. PubMed ID: 24025447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]